BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Prognosis
20 results:

  • 1. DKK3 expression is correlated with poorer prognosis in head and neck squamous cell carcinoma: A bioinformatics study based on the TCGA database.
    Katase N; Nishimatsu SI; Yamauchi A; Okano S; Fujita S
    J Oral Biosci; 2023 Dec; 65(4):334-346. PubMed ID: 37716425
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment.
    Iesato A; Li S; Sadow PM; Abbasian M; Nazarian A; Lawler J; Nucera C
    Thyroid; 2023 Jul; 33(7):835-848. PubMed ID: 37171127
    [No Abstract]    [Full Text] [Related]  

  • 3. cancer-associated fibroblasts in papillary thyroid carcinoma.
    Zhu L; Zhang X; Zhang S; Zhang Q; Cao L; Zhang Y; Wang D; Liang X; Wu W; Wu S; Jiang R; Liu Y; Zhao X; Zhou G; Xu K; Meng Z
    Clin Exp Med; 2023 Oct; 23(6):2209-2220. PubMed ID: 36715834
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Value of WNT1, NOTCH1, pdgfrβ, and CXCR4 in Oral Squamous Cell Carcinoma.
    Cierpikowski P; Lis-Nawara A; Bar J
    Anticancer Res; 2023 Feb; 43(2):591-602. PubMed ID: 36697060
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial.
    Li D; Chi Y; Chen X; Ge M; Zhang Y; Guo Z; Wang J; Chen J; Zhang J; Cheng Y; Li Z; Liu H; Qin J; Zhu J; Cheng R; Xu Z; Zheng X; Tang P; Gao M
    Clin Cancer Res; 2021 Jul; 27(13):3567-3575. PubMed ID: 33832949
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mining of gene modules and identification of key genes in head and neck squamous cell carcinoma based on gene co-expression network analysis.
    Zhao Q; Zhang Y; Zhang X; Sun Y; Lin Z
    Medicine (Baltimore); 2020 Dec; 99(49):e22655. PubMed ID: 33285674
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma.
    Chan JY; Lim JQ; Yeong J; Ravi V; Guan P; Boot A; Tay TKY; Selvarajan S; Md Nasir ND; Loh JH; Ong CK; Huang D; Tan J; Li Z; Ng CC; Tan TT; Masuzawa M; Sung KW; Farid M; Quek RHH; Tan NC; Teo MCC; Rozen SG; Tan P; Futreal A; Teh BT; Soo KC
    J Clin Invest; 2020 Nov; 130(11):5833-5846. PubMed ID: 33016928
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor prognosis in Oral Squamous Cell Carcinoma.
    Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Effect of Small-molecule Tyrosine Kinase Inhibitors on PDGF-AA/BB and pdgfrα/β Expression in SCC According to HPV16 Status.
    Huber L; Birk R; Rotter N; Aderhold C; Lammert A; Jungbauer F; Kramer B
    Anticancer Res; 2020 Feb; 40(2):825-835. PubMed ID: 32014925
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immune gene expression in head and neck squamous cell carcinoma patients.
    Lecerf C; Kamal M; Vacher S; Chemlali W; Schnitzler A; Morel C; Dubot C; Jeannot E; Meseure D; Klijanienko J; Mariani O; Borcoman E; Calugaru V; Badois N; Chilles A; Lesnik M; Krhili S; Choussy O; Hoffmann C; Piaggio E; Bieche I; Le Tourneau C
    Eur J Cancer; 2019 Nov; 121():210-223. PubMed ID: 31593831
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma.
    Tsao AS; Lin H; Carter BW; Lee JJ; Rice D; Vaporcyan A; Swisher S; Mehran R; Heymach J; Nilsson M; Fan Y; Nunez M; Diao L; Wang J; Fujimoto J; Wistuba II; Hong WK
    J Thorac Oncol; 2018 Feb; 13(2):246-257. PubMed ID: 29313814
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and pdgfrb.
    Song G; Liu K; Yang X; Mu B; Yang J; He L; Hu X; Li Q; Zhao Y; Cai X; Feng G
    Oncotarget; 2017 Mar; 8(11):17771-17784. PubMed ID: 28147311
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
    Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
    J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Coupling of LETM1 up-regulation with oxidative phosphorylation and platelet-derived growth factor receptor signaling via YAP1 transactivation.
    Lee J; Lee WK; Seol MY; Lee SG; Kim D; Kim H; Park J; Jung SG; Chung WY; Lee EJ; Jo YS
    Oncotarget; 2016 Oct; 7(41):66728-66739. PubMed ID: 27556512
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Efficacy of lenvatinib in treating thyroid cancer.
    Krajewska J; Kukulska A; Jarzab B
    Expert Opin Pharmacother; 2016 Aug; 17(12):1683-91. PubMed ID: 27398740
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.
    Czapiewski P; Kunc M; Haybaeck J
    Oncotarget; 2016 Aug; 7(32):52584-52596. PubMed ID: 27256979
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. KRAS, EGFR, pdgfr-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE).
    Veits L; Schupfner R; Hufnagel P; Penzel R; Freitag J; Ströbel P; Kern MA; Schröder S; Neuhold N; Schmid KW; Schirmacher P; Hartmann A; Rieker RJ
    Diagn Pathol; 2014 Jun; 9():116. PubMed ID: 24934485
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. High expression of SGTA in esophageal squamous cell carcinoma correlates with proliferation and poor prognosis.
    Yang X; Cheng L; Li M; Shi H; Ren H; Ding Z; Liu F; Wang Y; Cheng C
    J Cell Biochem; 2014 Jan; 115(1):141-50. PubMed ID: 23939810
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Expression of receptor tyrosine kinases in esophageal carcinosarcoma.
    Sano A; Sakurai S; Kato H; Suzuki S; Yokobori T; Sakai M; Tanaka N; Inose T; Sohda M; Nakajima M; Fukai Y; Miyazaki T; Ojima H; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Kuwano H
    Oncol Rep; 2013 Jun; 29(6):2119-26. PubMed ID: 23546020
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma.
    Mayr M; Becker K; Schulte N; Belle S; Hofheinz R; Krause A; Schmid RM; Röcken C; Ebert MP
    BMC Cancer; 2012 Dec; 12():587. PubMed ID: 23228190
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.